News Results
There are 467,511 News Results
Oct 27, 2023
Imperial (TSE: IMO, NYSE American: IMO): Third quarter Nine months millions of Canadian dollars, unless noted 2023 2022 ∆ 2023 2022 ∆ Net income (loss) (U.S. GAAP) 1,601 2,031 (430)...
Nov 2, 2023
HF Sinclair Corporation (NYSE: DINO) (“HF Sinclair” or the “Company”) today reported third quarter net income attributable to HF Sinclair stockholders of $790.9 million, or $4.23 per diluted share, for...
Nov 7, 2023
Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") today reported third quarter 2023 results. President and Chief Executive Officer Anton Dibowitz said, “We are pleased that VALARIS DS-17 commenced its...
Feb 21, 2024
HF Sinclair Corporation (NYSE:DINO) (“HF Sinclair” or the “Company”) today reported fourth quarter net loss attributable to HF Sinclair stockholders of $(62.2) million, or $(0.34) per diluted share, for the...
Feb 22, 2024
Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") today reported fourth quarter 2023 results. President and Chief Executive Officer Anton Dibowitz said, “We continue to execute on our operating leverage...
May 2, 2024
Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") today reported first quarter 2024 results. President and Chief Executive Officer Anton Dibowitz said, “I am very pleased with our start to...
May 9, 2024
Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2024 U.S. GAAP diluted earnings per share of $1.10 and adjusted earnings per share of...
May 9, 2024
STEP Energy Services Ltd. (the “Company” or “STEP”) is pleased to announce its financial and operating results for the three months ended March 31, 2024. The following press release should...
Feb 14, 2024
-- Revenue of $1,094.5 million vs. $969.9 million in prior year -- Earnings per share (EPS) from continuing operations of $0.18 vs. $0.24 in prior year -- Adjusted EPS((1) )of...
Feb 28, 2024
- Total revenues of $3.8 billion in 2023 and $1 billion in 4Q23 - - 27% year-over-year revenue increase from combined key growth drivers: Xywav(®), Epidiolex(® )and Rylaze(®) - -...
